Discover & Learn

The Alpha webinar series explores the benefits of Targeted Alpha Therapy (TAT) for cancer, featuring renowned speakers sharing their insights and expertise. In this first webinar, our two experts will delve into TAT distinctive radiobiological effects, its relevance for cancer care as well as the early experience and clinical progress in the field.

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

Get unique insights from experts in this ASNC webinar sponsored by IBA, featuring renowned experts who recently shared invaluable insights on launching a successful cardiac PET MPI program and advanced methods for measuring absolute blood flow with short-lived isotopes to enhance diagnosis and patient care.

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

By spotlighting on the crucial role of radiotheranostics in the fight against cancer, this webinar goes through the innovations and latest advancements in the field of radiotheranostics, featuring renowned experts in the field: Prof Dr Munir Ghesani, from United Radiotheranostics, US, and Prof Dr Christophe Deroose from UZ Leuven, Belgium.

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

Discover unique insights from esteemed experts in the field of Targeted Alpha Therapy, from the latest advancements in radiopharmaceutical development, through key clinical trials involving Actinium-225, to the early and upcoming trials with Astatine-211.

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

Get insights from world renowned experts in Cardiac PET Imaging and discover why this non-invasive medical imaging technique is a game-changer for early diagnosis and precise monitoring of cardiovascular diseases, especially coronary artery disease.
 

This webinar is already ready over. Missed the live webinar or want to rewatch it? 

As an international expert in radiopharmaceuticals, especially in cyclotron facilities and nuclear medicine research, Dr Richard Freifelder, PhD, shares his expertise in setting up cyclotron radiopharmacies by navigating through 2 case studies: an existing legacy space or a new, green space. From the accelerator’s choice, the programmatic goals to the regulatory compliance.
 

This webinar is already ready over. Missed the live webinar or want to rewatch it?